high-dose melphalan with autologous peripheral stem cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for high-dose melphalan with autologous peripheral stem cell transplantation, covering 2017-11-06 to 2017-11-06. Get the full timeline:
Most recent: Clinical Trial Update: S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis [Phase 2]